Allurion Technologies, Inc. Investing Cash Flow
Allurion Technologies, Inc. (ALUR) reported Investing Cash Flow of -$611.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-30
- Allurion Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- Allurion Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was -$72.00K.
- Allurion Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-06-30 was -$435.00K.
- Allurion Technologies, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was -$104.00K.
- Allurion Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$611.00K.
- Allurion Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$1.61M.
- Allurion Technologies, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$1.55M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$72.00K derived: sum of 2 quarters · filed 2026-03-30 | -$507.00K derived: sum of 3 quarters · filed 2026-03-30 | -$611.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$72.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-11-17 | -$507.00K derived: sum of 2 quarters · filed 2025-11-17 | -$611.00K 10-Q · filed 2025-11-17 | -$1.01M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$435.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$539.00K 10-Q/A · filed 2025-08-28 | -$937.00K derived: sum of 3 quarters · filed 2025-08-28 | -$1.74M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | -$104.00K 10-Q/A · filed 2025-08-28 | -$502.00K derived: sum of 2 quarters · filed 2025-08-28 | -$1.30M derived: sum of 3 quarters · filed 2025-08-28 | -$1.43M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | -$398.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | -$1.20M derived: sum of 2 quarters · filed 2025-08-28 | -$1.33M derived: sum of 3 quarters · filed 2025-08-28 | -$1.61M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | -$800.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2025-08-28 | -$931.00K derived: sum of 2 quarters · filed 2025-08-28 | -$1.21M 10-Q/A · filed 2025-08-28 | -$1.67M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | -$131.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2025-08-28 | -$408.00K 10-Q/A · filed 2025-08-28 | -$867.00K derived: sum of 3 quarters · filed 2025-08-28 | -$710.00K derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | -$277.00K 10-Q/A · filed 2025-08-28 | -$736.00K derived: sum of 2 quarters · filed 2025-08-28 | -$579.00K derived: sum of 3 quarters · filed 2025-08-28 | |
| 2022-12-31 | -$459.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | -$302.00K derived: sum of 2 quarters · filed 2025-08-28 | -$1.55M 10-K/A · filed 2025-08-28 | |
| 2022-09-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.09M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$1.25M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |